Bob Dylan was right: "The times they are a-changin'". And for Pfizer (PFE), those changing times mean navigating a post-pandemic world and a looming patent cliff. Can they rise to the challenge, or will they be singing the blues? Pfizer hardly needs an introduction. Founded 175 years ago in 1849 and publicly listed in 1942,
Global Market Comments May 30, 2024 Fiat Lux Featured Trade: (The Mad June traders & Investors Summit is ON!) SPECIAL EARLY RETIREMENT ISSUE (HOW TO JOIN THE EARLY RETIREMENT STAMPEDE)
Mad Hedge Technology Letter May 29, 2024 Fiat Lux Featured Trade: (THE GRIND HIGHER) (FED FUNDS RATE), ($COMPQ)
Rates will stay higher for longer and the higher income bracket will carry the US economy through any conflict with short-term inflation. What does that mean for tech stocks? It will trend higher for longer. Sure, US rates will stay elevated, but tech stocks have proven they are tough to keep down with elevated inflation.
“Study the past if you would define the future.” – Said Confucius
(BUCKLE UP WHEN FLYING - CLIMATE CHANGE MAY BE INCREASING CLEAR-AIR TURBULENCE) May 29, 2024 Hello everyone, Scientists at Reading University in the UK have studied clear-air turbulence. Their research shows that severe turbulence has increased by 55% between 1979 and 2020 on a typically busy North Atlantic route. Scientists have found that
Global Market Comments May 29, 2024 Fiat Lux Featured Trade: (WHY THE REAL ESTATE BOOM HAS A DECADE TO RUN), (DHI), (LEN), (PHM), (ITB)
When John identifies a strategic exit point, he will send you an alert with specific trade information as to what security to sell, when to sell it, and at what price. Most often, it will be to TAKE PROFITS, but, on rare occasions, it will be to exercise a STOP LOSS at a predetermined price to adhere to strict risk management discipline.
Mad Hedge Biotech and Healthcare Letter May 28, 2024 Fiat Lux Featured Trade: (GET YOUR GEIGER COUNTERS READY) (NVS), (LLY), (BMY), (AZN)
Hang on to your Geiger counters because we're about to dive deep into the world of radiopharmaceutical therapy. I bet even Marie Curie would be impressed by the mind-blowing leaps we've made since her ground-shattering discoveries a century ago. Now, don't get me wrong, she's a tough act to follow. But the big guns in